Neuroscience News

MDMA can instill in users an unguarded comfort among even the most unfamiliar of faces but is also prone to abuse. Stanford researchers have driven a wedge between these two aspects of the drug.

By Bruce Goldman

The default mode network, which controls the brain at rest, does not switch off in children with Type 1 diabetes when they focus on a task, a study led by Stanford scientists has shown.

Senior Erica Scott and coterminal student Mustafa Fattah have been named Marshall Scholars and will use the scholarship to pursue graduate degrees in the United Kingdom.

Protein levels in people’s blood can predict their age, a Stanford study has found. The study also found that aging isn’t a smoothly continuous process.

What’s really behind the sleepiness after a hearty Thanksgiving meal.

Stanford biologists are using rare poison frogs that nurse their young as a way to help answer a fundamental question: Is there more than one way to build a maternal brain?

When drugs fail, another option is deep brain stimulation, or DBS, where electrodes are placed in a specific brain region that helps control muscle activity.

We humans spend a third of our lives asleep, oblivious to our surroundings and temporarily paralyzed.

Hongjie Dai, Julie Parsonnet and Joseph Wu are among the 90 regular members and 10 international members elected this year to the academy, which aims to provide independent, scientifically informed analysis and recommendations on health issues.

A robotic surgical assistant known as ROSA™ recently helped experts at Lucile Packard Children's Hospital Stanford prepare for a minimally-invasive surgery to alleviate a little girl's seizures.

A discovery about a neural circuit located deep in the brains of female mice may give scientists a map to learn more about female human brains, according to a new study published in Cell and led by molecular neuroscientist Nirao Shah, MBBS, PhD.

Two pioneering scientists who transformed the fields of artificial intelligence and gene editing discuss the impacts of their technologies and the ethics of scientific discovery leading up to a public talk later this month.

The Stanford ChEM-H Building and the Stanford Neurosciences Building are opening this month as part of a new research complex dedicated to improving human health.

Five researchers were awarded grants from the National Institutes of Health to study opioid misuse and pain treatment.

In 2014, U.S. regulators approved a futuristic treatment for blindness. The device, called Argus II, sends signals from a glasses-mounted camera to a roughly 3-by-5-millimeter grid of electrodes at the back of eye.